Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan
· Delayed Price · Currency is TWD 29.00
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST
Prince Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Market Capitalization | 1,062 | 1,138 | 802 | 1,267 | - | - | Upgrade
|
| Market Cap Growth | 26.64% | 42.01% | -36.72% | - | - | - | Upgrade
|
| Enterprise Value | 1,331 | 1,502 | 1,180 | 1,670 | - | - | Upgrade
|
| Last Close Price | 29.00 | 31.10 | 21.90 | 34.68 | - | - | Upgrade
|
| PE Ratio | 11.11 | 11.82 | - | 82.75 | - | - | Upgrade
|
| PS Ratio | 1.01 | 1.08 | 1.16 | 1.68 | - | - | Upgrade
|
| PB Ratio | 1.27 | 1.36 | 1.11 | 1.64 | - | - | Upgrade
|
| P/TBV Ratio | 1.27 | 1.36 | 1.11 | 1.64 | - | - | Upgrade
|
| P/FCF Ratio | 14.78 | 15.85 | 28.42 | 2827.58 | - | - | Upgrade
|
| P/OCF Ratio | 11.79 | 12.64 | 17.35 | 20.27 | - | - | Upgrade
|
| EV/Sales Ratio | 1.26 | 1.42 | 1.71 | 2.22 | - | - | Upgrade
|
| EV/EBITDA Ratio | 7.72 | 9.18 | 259.75 | 21.99 | - | - | Upgrade
|
| EV/EBIT Ratio | 12.01 | 13.55 | - | 64.79 | - | - | Upgrade
|
| EV/FCF Ratio | 18.53 | 20.92 | 41.83 | 3728.36 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.50 | 0.64 | 0.63 | 0.80 | 0.94 | Upgrade
|
| Debt / EBITDA Ratio | 2.45 | 2.45 | 35.06 | 5.81 | 4.35 | 12.80 | Upgrade
|
| Debt / FCF Ratio | 5.88 | 5.88 | 16.33 | 1094.55 | 7.25 | 409.55 | Upgrade
|
| Net Debt / Equity Ratio | 0.32 | 0.32 | 0.50 | 0.48 | 0.69 | 0.82 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.65 | 1.65 | 78.80 | 4.84 | 3.97 | 12.32 | Upgrade
|
| Net Debt / FCF Ratio | 3.75 | 3.75 | 12.69 | 820.97 | 6.26 | 357.09 | Upgrade
|
| Asset Turnover | 0.74 | 0.74 | 0.50 | 0.56 | 0.55 | 0.35 | Upgrade
|
| Inventory Turnover | 4.78 | 4.78 | 4.34 | 4.11 | 3.68 | 2.79 | Upgrade
|
| Quick Ratio | 1.13 | 1.13 | 0.94 | 1.09 | 0.76 | 0.67 | Upgrade
|
| Current Ratio | 1.81 | 1.81 | 1.56 | 1.85 | 1.59 | 1.37 | Upgrade
|
| Return on Equity (ROE) | 12.34% | 12.34% | -7.16% | 2.14% | 8.18% | -1.37% | Upgrade
|
| Return on Assets (ROA) | 4.86% | 4.86% | -2.24% | 1.19% | 3.26% | -0.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.20% | 9.32% | -4.44% | 1.83% | 4.93% | -0.10% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.30% | 9.30% | -4.40% | 2.20% | 6.10% | -0.10% | Upgrade
|
| Earnings Yield | 9.07% | 8.46% | -6.68% | 1.21% | - | - | Upgrade
|
| FCF Yield | 6.76% | 6.31% | 3.52% | 0.03% | - | - | Upgrade
|
| Dividend Yield | - | - | - | 0.72% | - | - | Upgrade
|
| Payout Ratio | - | - | - | 35.46% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.03% | -1.03% | -0.09% | -9.66% | -0.41% | -1.45% | Upgrade
|
| Total Shareholder Return | -1.03% | -1.03% | -0.09% | -8.94% | -0.41% | -1.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.